US 9161995
Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (CFTR) gene
granted A61KA61K38/00A61K48/00
Quick answer
US patent 9161995 (Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (CFTR) gene) held by Sangamo Biosciences, Inc. expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Biosciences, Inc.
- Grant date
- Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K38/00, A61K48/00, A61K48/005, A61P